CD-19 | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

15,870 results for “CD-19”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

CD-19 CAR-T Cell for Pediatric ALL or Lymphoma

18 participants · First posted Mar 10, 2025

Anti-CD 19 CAR-T cell therapy in patients with ANCA Vasculitis - the IDEAL trial

8 participants · First posted Dec 9, 2024

Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus.

3 participants · First posted Nov 29, 2023

Addition of Nivolumab to Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive DLBCL at Lymphodepletion

20 participants · First posted May 23, 2022

A Safety and Efficacy Study of CD-19 t-haNK in Patients With B-cell Acute Lymphoblastic Leukemia

4 participants · First posted Apr 29, 2026

Active, not recruiting

Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis

13 participants · First posted Jun 26, 2024

Active, not recruiting

A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)

270 participants · First posted May 23, 2023

CAR19 Donor Lymphocytes for Relapsed CD19+ Malignancies Following Allogeneic Transplantation

17 participants · First posted Sep 8, 2016

Real World Practice With Academic Anti CD19 CAR-T Cell Therapy in Relapse/Refractory B-cell Lymphoma

76 participants · First posted Apr 13, 2026

XLCART001 Treatment in Relapsed/Refractory/High-risk B-cell Malignancy Subjects

10 participants · First posted Jul 26, 2018

Page 1 of 1059